Scott W Menzies

Summary

Affiliation: New South Wales
Country: Australia

Publications

  1. ncbi The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Arch Dermatol 141:1388-96. 2005
  2. doi Dermoscopic evaluation of amelanotic and hypomelanotic melanoma
    Scott W Menzies
    Faculty of Medicine, University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    Arch Dermatol 144:1120-7. 2008
  3. ncbi Cutaneous melanoma: making a clinical diagnosis, present and future
    Scott W Menzies
    Sydney Melanoma Diagnostic Center, Cancer Center, University of Sydney, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    Dermatol Ther 19:32-9. 2006
  4. doi Is sun exposure a major cause of melanoma? Yes
    Scott W Menzies
    University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, 2050 NSW, Australia
    BMJ 337:a763. 2008
  5. ncbi UV light from 290 to 325 nm, but not broad-band UVA or visible light, augments the formation of melanocytic nevi in a guinea-pig model for human nevi
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Institute, Royal Prince Alfred Hospital and Faculty of Medicine, University of Sydney, NSW 2006, Australia
    J Invest Dermatol 123:354-60. 2004
  6. doi The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face
    Pascale Guitera
    Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    J Invest Dermatol 130:2080-91. 2010
  7. doi Dermoscopic evaluation of nodular melanoma
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    JAMA Dermatol 149:699-709. 2013
  8. doi In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases
    Pascale Guitera
    Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia
    J Invest Dermatol 132:2386-94. 2012
  9. doi Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging
    Scott W Menzies
    Discipline of Dermatology, Sydney Medical School, University of Sydney and Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050 Australia
    Arch Dermatol 147:655-9. 2011
  10. doi Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma
    Davide Altamura
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Arch Dermatol 144:502-6. 2008

Detail Information

Publications28

  1. ncbi The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Arch Dermatol 141:1388-96. 2005
    ..To describe the diagnostic performance of SolarScan (Polartechnics Ltd, Sydney, Australia), an automated instrument for the diagnosis of primary melanoma...
  2. doi Dermoscopic evaluation of amelanotic and hypomelanotic melanoma
    Scott W Menzies
    Faculty of Medicine, University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    Arch Dermatol 144:1120-7. 2008
    ..To determine the predictive dermoscopic features of amelanotic and hypomelanotic melanoma...
  3. ncbi Cutaneous melanoma: making a clinical diagnosis, present and future
    Scott W Menzies
    Sydney Melanoma Diagnostic Center, Cancer Center, University of Sydney, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    Dermatol Ther 19:32-9. 2006
    ..Currently, other noninvasive diagnostic techniques, such as in vivo confocal scanning laser microscopy, are reserved for clinical research settings...
  4. doi Is sun exposure a major cause of melanoma? Yes
    Scott W Menzies
    University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, 2050 NSW, Australia
    BMJ 337:a763. 2008
  5. ncbi UV light from 290 to 325 nm, but not broad-band UVA or visible light, augments the formation of melanocytic nevi in a guinea-pig model for human nevi
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Institute, Royal Prince Alfred Hospital and Faculty of Medicine, University of Sydney, NSW 2006, Australia
    J Invest Dermatol 123:354-60. 2004
    ..Furthermore, because there was a significant decrease in nevi/animal receiving the full solar spectrum compared with the UVB group, it is possible that broad-band UVA and or visible light may be inhibitory wavebands for nevi induction...
  6. doi The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face
    Pascale Guitera
    Sydney Melanoma Diagnostic Centre and Dermatology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    J Invest Dermatol 130:2080-91. 2010
    ..In a test set of 29 LMs and 44 BMs, the OR for LM was 60.7 (confidence interval: 11.9-309) (93% sensitivity, 82% specificity)...
  7. doi Dermoscopic evaluation of nodular melanoma
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    JAMA Dermatol 149:699-709. 2013
    ..Nodular melanoma (NM) is a rapidly progressing potentially lethal skin tumor for which early diagnosis is critical...
  8. doi In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases
    Pascale Guitera
    Department of Dermatology, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia
    J Invest Dermatol 132:2386-94. 2012
    ..RCM is a highly accurate non-invasive technique for BCC diagnosis. Good diagnostic accuracy was achieved also for MM diagnosis, although rare variants of melanocytic tumors may limit the strict application of the algorithm...
  9. doi Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging
    Scott W Menzies
    Discipline of Dermatology, Sydney Medical School, University of Sydney and Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, 2050 Australia
    Arch Dermatol 147:655-9. 2011
    ..To determine whether certain patient demographics are associated with poorer specificity for the diagnosis of melanoma in nevi undergoing short-term sequential digital dermoscopic imaging...
  10. doi Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma
    Davide Altamura
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Arch Dermatol 144:502-6. 2008
    ..To determine whether 6 weeks could replace 3 months for short-term sequential digital dermoscopy imaging (ST-SDDI) of suspicious melanocytic lesions and determine the proportion of melanomas missed...
  11. ncbi Dermoscopy and its role in diagnosing melanocytic lesions: a guide for pathologists
    Kerry A Crotty
    Melanoma and Skin Cancer Research Institute, University of Sydney, NSW, Australia
    Pathology 36:470-7. 2004
    ..Several non-melanocytic pigmented lesions can be diagnosed with dermoscopy, including pigmented basal cell carcinoma, seborrhoeic keratoses, haemangioma and lichen planus-like keratosis...
  12. doi Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy
    Pascale Guitera
    Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia
    JAMA Dermatol 149:692-8. 2013
    ..Lentigo maligna (LM) is a clinical, pathologic, and therapeutic challenge with a higher risk of local recurrence than other types of melanoma correctly treated and also carries the cosmetically sensitive localization of head and neck...
  13. doi Morphologic features of melanophages under in vivo reflectance confocal microscopy
    Pascale Guitera
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia
    Arch Dermatol 146:492-8. 2010
    ..To determine morphologic features of melanophages under in vivo reflectance confocal microscopy (RCM) and to highlight morphologic features that are important in distinguishing melanophages from melanocytes...
  14. ncbi Dermoscopy of pigmented basal cell carcinoma
    Scott W Menzies
    Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Australia
    Clin Dermatol 20:268-9. 2002
  15. doi Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma
    Fergal J Moloney
    Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
    J Dermatol 38:10-5. 2011
    ....
  16. doi In vivo reflectance confocal microscopy enhances secondary evaluation of melanocytic lesions
    Pascale Guitera
    Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre and Dermatology Department, Royal Prince Alfred Hospital, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
    J Invest Dermatol 129:131-8. 2009
    ..3-94.5) compared with dermoscopy (specificity 39%, 95% CI: 23.7-56.2). Secondly, the RCM method classified 100% of the non-biopsied control nevi population as benign...
  17. ncbi Evidence-based dermoscopy
    Scott W Menzies
    Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia Discipline of Dermatology, Sydney Medical School, The University of Sydney, NSW 2006, Australia Electronic address
    Dermatol Clin 31:521-4, vii. 2013
    ..Furthermore, SDDI has been shown to reduce the excision of benign lesions when used in combination with dermoscopy. ..
  18. doi Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals
    Lucie Rychetnik
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, Australia
    J Surg Oncol 107:463-8. 2013
    ..There is limited evidence on the relative effectiveness of different follow-up schedules for patients with AJCC stage I or II melanoma, but less frequent follow-up than is currently recommended has been proposed...
  19. ncbi Enhanced survival in patients with multiple primary melanoma
    Anna Doubrovsky
    Sydney Melanoma Unit, Melanoma and Skin Cancer Research Institute, Department of Surgery, University of Sydney, Sydney, Australia
    Arch Dermatol 139:1013-8. 2003
    ..To calculate survival probabilities of patients with 3 or more multiple primary melanomas...
  20. doi Automated diagnostic instruments for cutaneous melanoma
    Malene E Vestergaard
    Department of Dermatology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
    Semin Cutan Med Surg 27:32-6. 2008
    ..Other image based nonclinic studies and studies comparing clinical management as the endpoint rather than diagnosis are also reviewed...
  21. doi Results of a nationwide dermoscopy survey investigating the prevalence, advantages and disadvantages of dermoscopy use among Australian dermatologists
    Supriya S Venugopal
    Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown NSW, Australia
    Australas J Dermatol 52:14-8. 2011
    ..The primary objective of this survey was to assess the prevalence of use of dermoscopy by Australian dermatologists. The secondary objective was to understand the perceived advantages and disadvantages of dermoscopy use...
  22. ncbi Why perform dermoscopy? The evidence for its role in the routine management of pigmented skin lesions
    Scott W Menzies
    Arch Dermatol 142:1211-2. 2006
  23. ncbi Technologies for the diagnosis of primary melanoma of the skin
    Scott W Menzies
    Med J Aust 185:533-4. 2006
    ..There is now an inexpensive first-line approach for diagnosing pigmented skin lesions...
  24. ncbi Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet
    Giuseppe Argenziano
    Department of Dermatology, Second University of Naples, Italy
    J Am Acad Dermatol 48:679-93. 2003
    ..There is a need for better standardization of the dermoscopic terminology in assessing pigmented skin lesions...
  25. ncbi Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma
    Peter Hersey
    Oncology and Immunology Unit, Room 443, David Maddison Clinical Sciences Building, King and Watt Streets, Newcastle, NSW, 2300, Australia
    Cancer Immunol Immunother 54:208-18. 2005
    ....
  26. ncbi Time to diagnosis of melanoma: same trend in different continents
    Andreas Blum
    Department of Dermatology, University of Tuebingen, Tuebingen, Germany
    J Cutan Med Surg 11:137-44. 2007
    ..Patients and physicians both play an important role in the diagnosis of malignant melanoma...
  27. ncbi Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens
    Farid H Saleh
    Department of Human Morphology, Faculty of Medicine, The American University of Beirut, PO Box 11 0236, Beirut, Lebanon FaridS l
    J Pathol 200:383-95. 2003
    ..No similar effects were observed with two other melanoma antigens, gp100 and CD63. Thus, in two groups of human melanoma patients, evidence is provided for histopathological tumour regression associated with cancer immune surveillance...
  28. ncbi Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
    Peter Hersey
    Oncology and Immunology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr King and Watt Streets, 2300, Newcastle, NSW, Australia
    Cancer Immunol Immunother 53:125-34. 2004
    ..DTH responses to autologous lysates appear useful predictors of clinical responses, but further work is needed to identify other measures associated with clinical responses...